COSCIENS Biopharma Inc. Issued Capital
COSCIENS Biopharma Inc. (CSCIF) had Issued Capital of $22.62 million as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes
ifrs-full:IssuedCapital · last filed 2026-03-25
- 2025-12-31: Issued Capital $22.62M.
- 2025-09-30: Issued Capital $22.62M.
- 2025-06-30: Issued Capital $22.60M.
- 2025-03-31: Issued Capital $22.50M.
| Period end | Issued Capital | Issued Capital as first filed |
|---|---|---|
| 2025-12-31 | $22.62M 20-F · filed 2026-03-25 | |
| 2025-09-30 | $22.62M 6-K · filed 2025-11-12 | |
| 2025-06-30 | $22.60M 6-K · filed 2025-08-14 | |
| 2025-03-31 | $22.50M 6-K · filed 2025-05-13 | |
| 2024-12-31 | $22.49M 20-F · filed 2026-03-25 | |
| 2024-09-30 | $22.39M 6-K · filed 2024-11-12 | |
| 2024-06-30 | $22.00M 6-K · filed 2024-08-13 | |
| 2024-03-31 | $293.41M 6-K · filed 2024-05-16 | |
| 2023-12-31 | $13.52M 20-F · filed 2025-04-09 | $293.41M 20-F · filed 2024-03-27 |
| 2023-09-30 | $293.41M 6-K · filed 2023-11-09 | |
| 2023-06-30 | $293.41M 6-K · filed 2023-08-09 | |
| 2023-03-31 | $293.41M 6-K · filed 2023-05-09 | |
| 2022-12-31 | $293.41M 20-F/A · filed 2024-07-17 | |
| 2022-09-30 | $293.41M 6-K · filed 2022-11-03 | |
| 2022-06-30 | $293.41M 6-K/A · filed 2022-08-04 | |
| 2022-03-31 | $293.41M 6-K · filed 2022-05-11 | |
| 2021-12-31 | $293.41M 20-F/A · filed 2024-02-15 | |
| 2021-09-30 | $293.35M 6-K · filed 2021-11-04 | |
| 2021-06-30 | $293.35M 6-K · filed 2021-08-05 | |
| 2021-03-31 | $293.78M 6-K · filed 2021-05-05 | |
| 2020-12-31 | $235.01M 20-F · filed 2022-03-29 | |
| 2020-09-30 | $235.01M 6-K · filed 2020-11-05 | |
| 2020-06-30 | $226.72M 6-K · filed 2020-08-06 | |
| 2020-03-31 | $226.41M 6-K/A · filed 2020-05-11 | |
| 2019-12-31 | $224.53M 40-F/A · filed 2021-03-29 | |
| 2019-09-30 | $224.53M 6-K · filed 2019-11-07 | |
| 2019-06-30 | $223.14M 6-K · filed 2019-08-13 | |
| 2018-12-31 | $222.34M 20-F · filed 2020-03-31 | |
| 2017-12-31 | $222.34M 20-F · filed 2019-04-01 | |
| 2016-12-31 | $213.98M 20-F · filed 2018-03-28 |